Plain and simple sean007. Leronlimab is a molecule that will be extremely disrupting to the bottom line of Gilead and the many other BIG pharma companies in the USA. When Leronlimab gets approved for anything, it's going to be very hard to stop the off label usage for the many indications that Vyrologix can be administered to patients all over the US and around the globe. Yes, Plain and Simple so that is the huge reason that not only the fda letter was posted at 3:15 the other day and the bombardment of the trading activities that are in the way of our share price. Again, Plain and Simple to me and I'm sure to the many others with large or small investments in CYDY.

I still will not sell one half of one share even now because Leronlimab works and all the company has to do now is get it into the trial arms with an abundance of power behind it meaning P-Value and it's all over for those with competing drugs - GLTU

HCIT